By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Miraculins has completed a private placement of 10.2 million units, raising C$510,000 (US$505,000) in proceeds.

The Winnipeg, Canada-based diagnostics firm said that it has sold the units at C$.05 each. The units are comprised of one common share and one share purchase warrant. Each warrant entitles the holder to purchase one share at a price of C$.10 for a period of 12 months after the warrant is issued.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.